MUCUS RELIEF EXTENDED RELEASE (GUAIFENESIN) TABLET [TARGET CORPORATION]

  • Home
  • MUCUS RELIEF EXTENDED RELEASE (GUAIFENESIN) TABLET [TARGET CORPORATION]

MUCUS RELIEF EXTENDED RELEASE (GUAIFENESIN) TABLET [TARGET CORPORATION]
PDF | XML
NDC 11673-732-14, 11673-732-28
Set ID e521e8e1-8227-451a-8858-01c26f6e0657
Category HUMAN OTC DRUG LABEL
Packager TARGET Corporation
Generic Name
Product Class
Product Number
Application Number ANDA207342
View All Sections
  • Active ingredient (in each extended-release tablet)

    Guaifenesin 1200 mg

  • Purpose

    Expectorant

  • Uses

    Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and makes coughs more productive.

  • Warnings

    Do not use

    for children under 12 years of age.

    Ask a doctor before use if you have

    • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema
    • cough accopanied by too much phlegm (mucus)

    Stop use and ask a doctor if

    cough lasts more than 7 days, comes back, or occurs with fever, rash or persistent headache. These could be signs of a serious illness.

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    • do not crush, chew, or break tablet
    • take with a full glass of water
    • this product can be administered without regard for the timing of meals
    • adults and children 12 years of age and over: take 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours.
    • children under 12 years of age: do not use 
  • Other information

    • store between 20º to 25ºC (68º to 77ºF)
  • Inactive ingredients

    carbomer, colloidal silicon dioxide, FD&C blue #1 aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, talc

  • Questions?

    Call 1-800-910-6874

  • Principal Display Panel

    Compare to active ingredient in Maximum Strength Mucinex®*

    maximum strength

    mucus relief

    guaifenesin 1200 mg

    expectorant

    relieves Chest Congestion

    thin & Loosens Mucus

    EXTENDED-RELEASE TABLETS

    *This product is not manufactured or distributed by Reckitt Benckiser LLC, distributor of Maximum Strength Mucinex®.

    KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.

    TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

    Distributed by Target Corporation

    Minneapolis,  MN 55403

    TM &©2018 Target Brands, Inc.

  • Package Label

    Guaifenesin 1200 mg

    TARGET Maximum Strength Mucus Relief

  • INGREDIENTS AND APPEARANCE
    MUCUS RELIEF EXTENDED RELEASE 
    guaifenesin tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11673-732
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN1200 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CARBOMER 934 (UNII: Z135WT9208)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    POVIDONE (UNII: FZ989GH94E)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    TALC (UNII: 7SEV7J4R1U)  
    Product Characteristics
    ColorBLUEScoreno score
    ShapeOVALSize6mm
    FlavorImprint Code AN037
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11673-732-1414 in 1 CARTON07/11/2018
    11 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:11673-732-2828 in 1 CARTON07/11/2018
    21 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20734207/11/2018
    Labeler - TARGET Corporation (006961700)
View All Sections

Related Drugs

Search DailyMed Drugs